Most Recent

image: “Hunger Hormone” No More?

“Hunger Hormone” No More?

By | April 20, 2016

Ghrelin promotes fat storage not feeding, according to a study.

3 Comments

image: Zooming In on an Antidepressant Target

Zooming In on an Antidepressant Target

By | April 6, 2016

Structural studies reveal how SSRI drugs bind to the human serotonin transporter.

0 Comments

image: New Epigenetic Mark Confirmed in Mammals

New Epigenetic Mark Confirmed in Mammals

By | April 1, 2016

Methylation on adenine bases is involved in the dampening of gene expression in mammalian cells, according to a study.

0 Comments

image: A Gut Feeling

A Gut Feeling

By | April 1, 2016

See profilee Hans Clevers discuss his work with stem cells and cancer in the small intestine.

0 Comments

image: Cancer's Vanguard

Cancer's Vanguard

By | April 1, 2016

Exosomes are emerging as key players in metastasis.

0 Comments

image: Cancerous Conduits

Cancerous Conduits

By | April 1, 2016

Metastatic cancer cells use nanotubes to manipulate blood vessels.

0 Comments

image: Guts and Glory

Guts and Glory

By | April 1, 2016

An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.

1 Comment

image: Tumor Traps

Tumor Traps

By | April 1, 2016

After surgery to remove a tumor, neutrophils recruited to the site spit out sticky webs of DNA that aid cancer recurrence.

0 Comments

image: A Different Way of Doing Things

A Different Way of Doing Things

By | April 1, 2016

Cancer cells exhibit altered metabolic processes that may serve as promising targets for new therapies.

0 Comments

image: Metabolic Reprogramming

Metabolic Reprogramming

By | April 1, 2016

How cancer cells fuel their rapid growth

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech